Vertex Pharmaceuticals Incorporated (FRA:VX1)
391.85
+0.45 (0.11%)
Last updated: May 13, 2025
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 6,100 employees as of December 31, 2024. The number of employees increased by 700 or 12.96% compared to the previous year.
Employees
6,100
Change (1Y)
700
Growth (1Y)
12.96%
Revenue / Employee
€1,683,515
Profits / Employee
€149,989
Market Cap
99.29B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Siemens Healthineers AG | 72,000 |
Vertex Pharmaceuticals News
- 7 days ago - Vertex Pharmaceuticals Incorporated (VRTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Vertex misses on both lines in Q1 as 2025 revenue forecast narrowed - Seeking Alpha
- 8 days ago - Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance - Benzinga
- 8 days ago - Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug - Reuters
- 8 days ago - Vertex Pharmaceuticals Non-GAAP EPS of $4.06 misses by $0.23, revenue of $2.77B misses by $90M - Seeking Alpha
- 8 days ago - Vertex Reports First Quarter 2025 Financial Results - Business Wire
- 8 days ago - Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum? - Benzinga
- 8 days ago - Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum? - Benzinga